To test the pathophysiological relevance of our findings, we turned our attention to human PDX leukemia specimens, which were derived from patients with B-precursor acute lymphoblastic leukemia treated with asparaginase-intensive combination chemotherapy on contemporary clinical trials (Figure 7H; Table S3). Here, ASPG is linked to acute lymphoblastic leukemia.